 Following the Monday holiday, the equities sector got off to a slow start for the Jan. 17 session, with Pfizer NYSE: PFE conspicuously declining more than 3 in the early afternoon hours. Unfortunately for the pharmaceutical stalwart, a Wells Fargo analyst downgraded PFE stock, citing a need for a readjustment of expectations surrounding its coronavirus-related solutions. 